1 - 15 of 26 Results Clear All
Gladstone began as a single entity with a single purpose. But as the scientists followed the science—unencumbered by the red tape of bureaucracy—the purpose, and the focus, grew.
History Institutional News Cardiovascular Disease Data Science and Biotechnology Neurological Disease Virology and Immunology Finkbeiner Lab Greene Lab Mahley Lab Mucke Lab
Since Shinya Yamanaka discovered a method to create human induced pluripotent stem cells (hiPS cells), Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.
Research Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing Stem Cells/iPSCs
A Seattle native, David grew up exploring the great wild places in this country and beyond. He explains the role of a lab manager at Gladstone, as well as his love of wilderness travel, for which knowing how to pack efficiently is a useful skill.
The Psychiatric Cell Mapping Initiative is led by researchers at Gladstone and UC San Francisco
Grants News Release Epilepsy Virology and Immunology Doudna Lab Finkbeiner Lab Krogan Lab
Gladstone and Google AI collaborate to uncover the tip of an iceberg that could transform biomedical science
These centers focus on thematic areas that impact numerous scientific disciplines
Institutional News HIV/AIDS Center for Cell Circuitry Center for HIV Cure Research Center for Systems and Therapeutics Finkbeiner Lab Greene Lab Weinberger Lab
Study will use innovative technology to focus on neurodegenerative diseases
Business Development News Release Finkbeiner Lab
The ALS Association recognized Steven Finkbeiner’s pioneering work and urgent focus to bring effective treatments to patients with ALS.
Finkbeiner Lab
The funded program will, for the first time, introduce gene editing and stem cell therapies in the search for a potential cure
Finkbeiner Lab
Scientists have developed sophisticated models to unravel complex human biology in their pursuit of cures.
Finkbeiner Lab McDevitt Lab Ott Lab Sanjabi Lab Zika Virus Hepatitis C
Steven Finkbeiner was selected for the award based on his history of exceptional talent, imagination, and preeminent scientific achievement in finding better treatments for Huntington’s disease.
Finkbeiner Lab
Gladstone’s Bioinformatics Core is dedicated to providing expertise in data analysis and visualization to answer complex biological questions with Big Data.
Bruneau Lab Finkbeiner Lab Big Data
Scientists discover an enzyme that that could be targeted to treat both Alzheimer’s disease and frontotemporal dementia.
Finkbeiner Lab
New details learned about a key cellular protein could lead to treatments for neurodegenerative diseases, such as Parkinson’s, Huntington’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS).
Finkbeiner Lab
Changing a specific part of the huntingtin protein prevented the loss of critical brain cells and protected against behavioral symptoms in a mouse model of the disease.
Finkbeiner Lab